Current Research of Chlamydial Infection Diseases in China

Abstract

To the Editor: Chlamydia organisms belong to intracellular bacterial pathogens which are responsible for a range of human diseases, including trachoma, sexually transmitted disease, pneumonia, and other diseases.[1 2 3 4 5] Some Chlamydia-infected diseases were old and had long time impacted on the people's health in China and worldwide, but people cannot put enough emphasis on itin local areas.[6] For example, although China had reached the goal of eliminating blinding trachoma in 2015, some sporadic cases also exist in rural counties. Moreover, few of studies were conducted on pneumonia induced by Chlamydia in China due to the present low prevalence and the limited detective methods. Sexually transmitted Chlamydia trachomatis infection also has notorious effects on reproduction, often asymptomatic and recurrent; thus, chlamydial infection diseases remain important public health concern over its prevention and control. This article focuses on the importance of caring about Chlamydia spp. and discusses taxonomy, prevalence, and laboratory diagnosis methods of Chlamydia diseases in China. Chlamydiae comprises 11 species that are pathogenic.[7] C. trachomatis and C. pneumoniae are the two major species easily infected by humans, and others are zoonotic and always transmitted from animals to humans.[8 9 10 11] Table 1 lists the six kinds of most common Chlamydia species and related diseases. C. trachomatis have different serovars: A, B, Ba, and C lead to trachoma, D to K lead to genital tract Chlamydia infection, and L1–L3 lead to lymphogranuloma venereum. All the species, other than C. abortus, can induce community-acquired pneumonia (CAP) in humans [Table 1]. Table 1 Taxonomy of Chlamydia spp., the associated diseases, typing methods and epidemiology Pathogen Host Serotyping method designation Target loci Discrimination type C. trachomatis Human MOMP serotyping ompA Immunoreactivity ELISA ompA Immunoreactivity MLST 7 house keeping genes SNPs Real-time PCR ompA + pmpH SNPs + indels PCR-sequencing ompA SNPs PCR-RFLP ompA DNA restriction patterns PFGE Genomic DNA SNPs Whole-genome sequencing Genome All polymorphisms C. pneumoniae Animal and human Do not need serotyping C. psittaci, C. caviae, C. felis, C. abortus Animal-to-human transmission Do not need serotyping Pathogen Diseases Countries Prevalence Population Main serotypes C. trachomatis Trachoma Australia 15.4–43.9% Children Ba/C Iran 5.9–10.8% Children B/C Niger 10.0% Children Ba India 35.0% >15 years old B/C Gambia 6.7% Children Ba Tanzania 32.3% Children A Ethiopia 35.6% Children Ba Brazil 4.7% Children A China <5.0% Children B Genital tract chlamydia infection China 2.1% (men)/2.6% (women) Adults E, F, G, D LEV Netherlands 0.9% Men who have sex with men L1–L3 UK 0.9% Pneumonia 7.2% Infants E, F, J, D, K, G, H C. pneumoniae Pneumonia German 1.4% Adults Brazil 5.2% Children United States 8.0% Adults Canada 8.0% Adults China 3.5% Children Asthma, arthritis, cerebrovascular disease, atherosclerosis Seldom research C. psittaci Pneumonia Worldwide 1.0% C. caviae, C. felis Pneumonia Seldom research C. abortus Abortion, stillbirth, septicemia Seldom research SNPs: Single-nucleotide polymorphisms; PCR: Polymerase chain reaction; RFLP: Restriction fragment length polymorphism; MOMP: Major outer membrane protein; MLST: Multilocus sequence typing; PFGE: Pulsed-field gel electrophoresis; LGV: Lymphogranuloma venereum. Chlamydia spp. has two kinds of life forms related to infection: the elementary body (EB) and the reticulate body (RB). Among them, EB is the main body of infectious stage and RB is related to the replicative form. The host cell is invaded by EB of Chlamydia and then EB is transmitted to RB. Its replication is induced by binary fission and is released out with infectious EB by redifferentiation.[12] EB maintains structure by disulfide-bridge protein complex. The feature explains the resistance of Chlamydia spp. to antibiotics targeting bacterial cell wall biosynthesis, such as penicillins.[13] Genome structure and virulence are different among species.[14] Trachoma was important blindness disease in China in the last century. The pathogen of trachoma was first observed by FF Tang in 1956 by cell culture in chicken embryo. In liberation stage, nine out of ten people were caught in trachoma. Through surgery for trichiasis, antibiotic treatment, face washing, and environmental improvements strategy, the prevalence of trachoma has sharply declined in recent decades.[15] In 2015, it was pronounced that trachoma has been eliminated in China (prevalence <5%). Nowadays, only sporadic cases were found in local areas, such as Qinghai province.[16] Some other countries [Table 1] also have existing trachoma and the prevalence was ranged from 4.7% to 43.9%, while China has low morbidity of trachoma in developing countries. Australia is the only highly income country with persisting endemic trachoma.[17 18 19 20 21 22 23] C. trachomatis serotypes differ across regions. Serotype B was common in China and other countries in Asia, while serotype A, Ba, and C were more popular in Tanzania, Brazil, Morocco, North Africa, and Australia[6 24] [Table 1]. The prevalence of pneumonia due to C. pneumoniae was reported to be much lower nowadays than previous years.[25 26] Different countries had variable morbidity, from 1.4% to 8.0% listed in [Table 1].[25 27 28 29 30] In China, C. pneumoniae was found in 3.5% of CAP cases in children and 2.7% in adults. China had less disease prevalence than some other developing countries Table 1. Other Chlamydia spp. can induce pneumonia, including C. trachomatis, C. psittaci, C. caviae, and C. felis. C. trachomatis can also be transferred from cervix to amniotic cavity or via the placenta.[8 9 10 31] There are approximately 100–150 million new C. trachomatis cases occurring annually worldwide, affecting 68 million females.[32 33] 75–90% of the patients usually do not exhibit any symptoms in both men and women.[34] In 20–40% of untreated women, C. trachomatis may reach the fallopian tubes via the endometrial epithelium and cause pelvic inflammatory disease, and this silent infection can lead to tubal factor infertility, miscarriage, or ectopic pregnancy, which is a life-threatening condition.[35 36] Untreated or inadequately treated patients also risk spreading the infection to sexual partners. It is estimated that 5 out of 1000 C. trachomatis-infected women will develop tubal factor infertility.[37] In males, epididymitis is the most severe complication.[33] In 2014, there were 1,441,789 chlamydial infections reported to the US Centers for Disease Control and Prevention in 50 USA states and the District of Columbia, which represents a 2.8% increase compared with the past 2 years. In China, using a national stratified probability sampling technique and urinary ligase chain reaction diagnostics, Parish et al. found relatively high prevalence per 100 population of 2.1% among men and 2.6% among women aged 20–64 years for genital chlamydial infection, and chlamydial infection is much more common than gonorrheal infection in the general population.[38] The prevalence of chlamydial infection among sex workers is 32%.[39] Genital C. trachomatis infection also promotes the transmission of HIV and is associated with cervical cancer. Detecting nucleotide sequence differences in the major outer membrane protein gene (ompA) of the different serovars is the new routine method to classify different strains of C. trachomatis. E, F, and D account for up to 60–70% of the infection.[40] Genotypes with E (27.9%), F (23.5%), G (12.4%), and D (11.1%) were most prevalent in China.[41] Asthma, arthritis, cerebrovascular disease, carotid atherosclerosis, age-related macular degeneration, and abortion can also be induced by Chlamydia spp.[1 2 3 5 42] The trachomatous inflammation-follicular could alternatively be due to organisms other than C. trachomatis.[24 43] Copan swabs were recommended for sample collection.[44] Several testing methods, such as culture, serology, immunofluorescence test, complement fixation test and PCR were applied in detection. The strain can only be acquired through cell culture.[45] Although nucleic acid amplification techniques were highly sensitive and specific and were used widely in recent years, some new methods such as anti-Pgp3 antibodies of dried blood spots have been developed.[24 31 46 47] According to different targets, several typing methods were applied, too [Table 1]. Among them, only whole-genome sequencing targets all polymorphisms, others target ompA or single-nucleotide polymorphisms.[9 24] For the laboratory diagnosis of C. pneumoniae, lower respiratory specimens were needed for detection, not swabs. To identify C. pneumoniae from other respiratory organisms, multiplex polymerase chain reaction was recommended [Table 1]. Nucleic acid amplification tests are currently recommended method to detect genital tract Chlamydia infection.[48] Noninvasive sampling (urine or vaginal) is as effective as invasive sampling of vaginal, endocervical, or penile urethral swab and is more acceptable to patients. Rectal and oropharyngeal C. trachomatis infection can be diagnosed by testing at the anatomic site of exposure. To decrease the number of C trachomatis patients, oral azithromycin or topical tetracycline was used in endemic communities. However, some studies reported that Chlamydia isolates were heterotypic resistance to macrolides (including azithromycin) in vitro. The World Health Organization recommends mass drug administration for infection control and should continue until the prevalence of trachomatous inflammation-follicular in falls below 5% in subdistricts or community clusters.[13 49] C. pneumoniae is generally considered susceptible to antibiotics interfering with prokaryotic DNA, RNA, or protein synthesis, such as quinolones, tetracyclines, and macrolides, but in contrast to C. trachomatis, it was not sensitive to trimethoprim or sulfonamides.[13] For uncomplicated genital Chlamydia infection, treatment with single-dose azithromycin or 7 days of doxycycline for men and nonpregnant women is recommended, with doxycycline less preferred because of compliance issues.[50] It has demonstrated >95% microbiological cure after 2–5-week therapy, with few antimicrobial resistances being documented and no examples of natural and stable antibiotic resistance in strains collected from humans.[51] Due to the intracellular characteristics of Chlamydia spp., it is difficult to culture and get the strains of the Chlamydia spp., so vaccine was not available for Chlamydia diseases now. Acquired immunity to reinfection is serovar specific, weak, and short lived. Although the prevalence of Chlamydia diseases is sporadic in local areas, limitation of detective method in the areas may be the reason, not real representation of diseases. Hence, Chlamydia spp. and the associative diseases are worth to be noticed in future, especially in developing countries.[52] Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.